The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics
Open Access
- 1 December 2017
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (51) , 21137-21148
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (DK103022)
This publication has 50 references indexed in Scilit:
- Quit your YAPing: a new target for cancer therapy: Figure 1.Genes & Development, 2012
- Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAPGenes & Development, 2012
- Cell Biology and Pathology of PodocytesAnnual Review of Physiology, 2012
- Regulation of AMPA Receptor Function by the Human Memory-Associated Gene KIBRANeuron, 2011
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Structural insights into the YAP and TEAD complexGenes & Development, 2010
- Kibra Functions as a Tumor Suppressor Protein that Regulates Hippo Signaling in Conjunction with Merlin and ExpandedDevelopmental Cell, 2010
- TEAD mediates YAP-dependent gene induction and growth controlGenes & Development, 2008
- Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth controlGenes & Development, 2007
- Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytesProceedings of the National Academy of Sciences, 2007